Concepedia

Surgery in recurrent epithelial ovarian cancer: Benefits on Survival for patients with residual disease of 0.1–1 cm after secondary cytoreduction

Wen‐Juan Tian, Rong Jiang, Xi Cheng, Jie Tang, Yan Xing, Rongyu Zang

Journal of Surgical Oncology · 2010 · 49 citations · 22 references

DOI

Abstract

Complete secondary cytoreduction is the strongest survival determinant in recurrent epithelial ovarian cancer, whereas patients with residual disease of 0.1-1 cm may also benefit from secondary cytoreduction.

References

22

Prognostic Factors for Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study

William E. Winter, G. Larry Maxwell, Chunqiao Tian et al. · Journal of Clinical Oncology · 2007 · 839 citations · Full text

The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma

Mark F. Brady, Harrison Ball, Jonathan S. Berek · American Journal of Obstetrics and Gynecology · 1994 · 670 citations

, , +8

What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?

D.S. Chi, Eric Eisenhauer, J. Lang et al. · Gynecologic Oncology · 2006 · 624 citations

, , +9

The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma

International Journal of Gynecology & Obstetrics · 1995 · 555 citations

, , +8

Surgery in Recurrent Ovarian Cancer: The Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR Trial

Philipp Harter, Andreas du Bois, Maik Hahmann et al. · Annals of Surgical Oncology · 2006 · 415 citations

, , +10